Modified submental platysmal adipomyofascial flap: is it a reliable alternate reconstructive option for small- to mid-sized defects especially in male patients with oral/oropharyngeal cancer?

Abstract

Purpose To introduce modified submental platysmal adipomyofascial flap as a new and viable hairless locoregional option for reconstruction of small-to mid-sized defects after ablative surgery in oral/oropharyngeal cancer patients keeping in mind the present pandemic situation. Methods An observational retrospective study was conducted using modified submental platysmal adipomyofascial flap as a locoregional reconstructive option for both intraoral and oropharyngeal defects in early-stage oral/oropharyngeal cancer patients, from Jan 2016 to May 2020 in a tertiary care hospital. All patients in this study were male and the overall flap outcome was evaluated with post-operative follow-up. Results Out of 18 patients, in 4 patients modified submental platysmal adipomyofascial flap was used as a combination of flaps for reconstruction. Six patients (33.33%) underwent adjuvant radiation therapy/radiation chemotherapy. The long-term functions (speech and swallowing) and cosmetic outcomes were good in the majority of the patients. One patient (5.55%) had pinhole oroantral fistula. No patient had any major flap failure. Conclusion Modified submental platysmal adipomyofascial flap can be considered as a good alternative in male patients for reconstruction of small-to mid-sized oral cavity/oropharyngeal defects post-resection, especially during the prevailing pandemic crisis. It is an oncologically safe procedure with the major advantage of providing a hairless flap for oral cavity, tonsillar and BOT resection defects with lesser donor site morbidity.

Efficacy of c isplatin in combination with paclitaxel for oral cancer and its effect on cellular immunity

“…Oral cancer is clinically treated with surgical resection, supplemented with radiotherapy and chemotherapy [15], yet both have a high degree of recurrence and metastasis. Cisplatin is a clinical anticancer drug [16] with cell cycle nonspecificity. It inhibits the synthesis of DNA and RNA to exert anti-tumor effects.…”

Indication for management of oropharyngocutaneous fistulas after head and neck reconstruction using a “stick‐shaped platysma flap” technique

“…3 Moreover, Singh et al reported that the present scenario of the COVID-19 pandemic crisis requires alternative locoregional options for flap reconstruction in the head and neck rather than free flaps due to the increased emphasis on less operative time, shorter flap harvest time, and less postoperative complications and shorter hospital stay. 4 In our experience, four patients have undergone successful fistula repair with use of our novel stick-shaped platysma flap technique from June 2016 to April 2020 (Table 1). Herein, we report representative cases.…”

“…Moreover, Singh et al reported that the present scenario of the COVID‐19 pandemic crisis requires alternative locoregional options for flap reconstruction in the head and neck rather than free flaps due to the increased emphasis on less operative time, shorter flap harvest time, and less postoperative complications and shorter hospital stay 4 …”